Trial Profile
A Phase 2a trial of OPK88002 to treat pruritus (itching) in Stage 5 CKD patients undergoing dialysis
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 17 Aug 2018
Price :
$35
*
At a glance
- Drugs OPK88002 (Primary)
- Indications Pruritus
- Focus Therapeutic Use
- Sponsors OPKO Health
- 08 Aug 2018 According to an Opko health media release, this study is expected to begin in 2018.
- 08 Aug 2017 According to an Opko health media release, this study expected to begin in late 2017.
- 08 Aug 2017 According to an Opko health media release, Investigational New Drug application has been approved.